Enzoshine Plus Tablet DT is a combination pharmaceutical formulation containing Trypsin 48 mg, Bromelain 90 mg, Rutoside 100 mg, and Diclofenac 50 mg, designed for the management of inflammatory conditions and associated pain. Trypsin and Bromelain are proteolytic enzymes that facilitate the breakdown of proteins and exhibit anti-inflammatory and anti-edematous properties, promoting the resolution of inflammation and enhancing tissue repair. Rutoside, a bioflavonoid, acts as a vascular protector by strengthening capillary walls and reducing capillary permeability, thereby minimizing edema and bruising. Diclofenac, a non-steroidal anti-inflammatory drug (NSAID), provides potent analgesic and anti-inflammatory effects by inhibiting cyclooxygenase enzymes, leading to decreased prostaglandin synthesis. The combination of these agents offers a synergistic effect, making Enzoshine Plus Tablet DT effective in treating musculoskeletal disorders, postoperative inflammation, soft tissue injuries, and other conditions characterized by pain and swelling. The orally disintegrating tablet (DT) formulation ensures rapid disintegration and absorption, facilitating prompt onset of action and improved patient compliance, especially in individuals with difficulty swallowing. Enzoshine Plus should be used under medical supervision, considering contraindications related to NSAIDs and enzyme therapy.